1800 202 8726
Bevacizumab eligibility

Who Is Eligible for — Bevacizumab?

Your oncologist has prescribed bevacizumab, and you want to understand why it applies to you and not everyone else. Eligibility is based on your cancer type and your general health — not a biomarker test. Knowing what was checked helps you ask the right questions at your next appointment.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026

  • No biomarker test required — Bevacizumab does not need PD-L1, MSI or TMB testing. Your cancer type and stage decide whether it applies.
  • Approved for several cancer types — It is used in colorectal, ovarian, cervical, and non-squamous lung cancer, and in glioblastoma.
  • Health history matters too — Uncontrolled high blood pressure, recent surgery, or a history of serious bleeding can rule it out.
  • Given as a day-care infusion — Bevacizumab is usually given alongside chemotherapy through an IV drip, not as a tablet taken at home.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Bevacizumab is used in specific cancer types — including colorectal, ovarian, cervical, non-squamous lung cancer, and glioblastoma — and does not require a biomarker test before it is prescribed. Whether you are suitable also depends on your general health, especially your blood pressure, wound-healing history, and any planned surgery.

How does your oncologist decide whether bevacizumab suits you?

Bevacizumab works differently from immunotherapy or targeted therapies that need a specific gene mutation to be present. There is no PD-L1 score, no MSI result, and no gene panel to wait for.

The first question is whether your cancer type is one where bevacizumab is part of the standard treatment approach. The second question is whether your general health — particularly blood pressure, wound healing, and clotting history — makes it safe to use.

If your oncologist has recommended it, both of those questions have already been considered.

Which cancer types is bevacizumab used for?

  • Metastatic colorectal cancerGiven alongside chemotherapy, typically from the start of treatment for metastatic disease.
  • Non-squamous non-small cell lung cancerOnly non-squamous histology — squamous cell type carries a different risk profile.
  • Ovarian, fallopian tube, and peritoneal cancerUsed in advanced and relapsed disease, combined with chemotherapy.
  • Cervical cancerIn recurrent or advanced disease, given alongside chemotherapy.
  • GlioblastomaAn aggressive brain tumour; used when it recurs after initial treatment.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What health conditions can rule bevacizumab out?

Bevacizumab affects how blood vessels form and how wounds heal, which means certain conditions make it unsafe to use.

Recent major surgery is one of them. Your team will plan a gap between any operation and your bevacizumab infusions — both before and after surgery — to protect wound healing.

High blood pressure that is not well controlled, a history of serious bleeding, a history of arterial blood clots such as a stroke or heart attack, and pregnancy can also mean bevacizumab is not the right choice. Your oncologist will review your medical history specifically to check for these before treatment starts.

Did you know?

Bevacizumab works by blocking a protein called VEGF, which tumours use to grow new blood vessels for themselves.

Without that blood supply, tumours are less able to grow and spread — which is why this class of drug is called anti-angiogenic.

Source: NCCN Clinical Practice Guidelines in Oncology

Explore 100 more Gastrointestinal & Liver Targeted Medicines topics

All Gastrointestinal & Liver Targeted Medicines →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Does bevacizumab need a biomarker test before I can have it?

No. Unlike immunotherapy, which needs PD-L1, MSI or TMB results from your tumour tissue, bevacizumab does not require biomarker testing. Your oncologist decides whether it is appropriate based on your cancer type, stage, and health history. If you have heard about biomarker testing in the context of your treatment, ask your team specifically which tests apply to you — the answer depends on which treatments are being considered.

Can I have bevacizumab if I have high blood pressure?

High blood pressure that is well controlled is usually manageable, and your team will monitor it closely throughout treatment. Bevacizumab can raise blood pressure further, so if yours is already difficult to control, your oncologist will weigh that risk carefully before proceeding. Tell your team about every blood pressure medication you take, including anything prescribed by a doctor outside your oncology team.

Why is bevacizumab not used for squamous cell lung cancer?

Squamous cell lung tumours tend to sit close to large blood vessels in the central chest. Bevacizumab affects blood vessel walls, and in squamous cell histology that combination carries a risk of serious bleeding that is considered too high. Non-squamous types — such as adenocarcinoma — have a different anatomy and a more acceptable risk profile. Your pathology report determines which type you have, and your oncologist will explain what that means for your options.

Will I need to stop bevacizumab before surgery?

Yes. Because bevacizumab slows wound healing, your treatment is paused around any surgical procedure — usually for several weeks before and after the operation. This applies to planned operations of all kinds, including procedures under general anaesthetic. Tell your oncology team about any planned surgery as early as possible so the timing can be managed safely, and do not assume a minor procedure is too small to mention.

Is bevacizumab given on its own or alongside chemotherapy?

In most settings it is given alongside chemotherapy rather than as a standalone treatment. It works by cutting off the blood supply a tumour builds for itself, while chemotherapy acts on the cancer cells directly — the two approaches are intended to work together. The specific chemotherapy regimen depends on your cancer type. Your oncologist will explain the combination being planned for you and what to expect from each part of it.

Is this treatment available at CION?

Infusion-based cancer treatment is available as day care at CION centres — you come in for your infusion and go home the same day. Ask your care team which centre handles your treatment and what to bring on infusion day. If your care plan also includes scans such as PET-CT, those are coordinated with partner imaging centres.

Call now Book free consultation